Autor: "Kraakman MJ" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis.
Autorzy:: Dragoljevic D; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Lee MKS; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Pernes G; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Morgan PK; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Louis C; Inflammation Division Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.; Rheumatology Unit Royal Melbourne Hospital Melbourne VIC Australia.
Shihata W; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Huynh K; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Kochetkova AA; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Bell PW; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Mellett NA; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Meikle PJ; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Lancaster GI; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Department of Immunology Monash University Melbourne VIC Australia.
Kraakman MJ; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Nagareddy PR; Department of Surgery Ohio State University Wexner Medical Center Columbus OH USA.
Hanaoka BY; Department of Surgery Ohio State University Wexner Medical Center Columbus OH USA.
Wicks IP; Inflammation Division Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.; Rheumatology Unit Royal Melbourne Hospital Melbourne VIC Australia.
Murphy AJ; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Pokaż więcej
Źródło:: Clinical & translational immunology [Clin Transl Immunology] 2023 Apr 18; Vol. 12 (4), pp. e1446. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis.
Autorzy:: Dragoljevic D; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Department of Immunology Monash University Melbourne VIC Australia.
Lee MKS; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Department of Immunology Monash University Melbourne VIC Australia.
Louis C; Inflammation Division Walter and Eliza Hall Institute of Medical Research Melbourne VIC Australia.
Shihata W; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Kraakman MJ; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.
Hansen J; Inflammation Division Walter and Eliza Hall Institute of Medical Research Melbourne VIC Australia.
Masters SL; Inflammation Division Walter and Eliza Hall Institute of Medical Research Melbourne VIC Australia.
Hanaoka BY; Department of Surgery Ohio State University Wexner Medical Center Columbus OH USA.
Nagareddy PR; Department of Surgery Ohio State University Wexner Medical Center Columbus OH USA.
Lancaster GI; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Department of Immunology Monash University Melbourne VIC Australia.
Wicks IP; Inflammation Division Walter and Eliza Hall Institute of Medical Research Melbourne VIC Australia.; Rheumatology Unit Royal Melbourne Hospital Melbourne VIC Australia.
Murphy AJ; Division of Immunometabolism Baker Heart and Diabetes Institute Melbourne VIC Australia.; Department of Immunology Monash University Melbourne VIC Australia.; Pokaż więcej
Źródło:: Clinical & translational immunology [Clin Transl Immunology] 2020 Nov 09; Vol. 9 (11), pp. e1206. Date of Electronic Publication: 2020 Nov 09 (Print Publication: 2020).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
Autorzy:: Kammoun HL; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.; Immunology department, Monash University, Melbourne, Australia.
Allen TL; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.
Henstridge DC; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.
Kraakman MJ; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.
Peijs L; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.
Rose-John S; Department of Biochemistry, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
Febbraio MA; Cellular and Molecular Metabolism Laboratory, Baker Heart & Diabetes Institute, Melbourne, Australia.; Cellular and Molecular Metabolism, Garvan Institute, Sydney, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Jun 20; Vol. 12 (6), pp. e0179099. Date of Electronic Publication: 2017 Jun 20 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Choline Deficiency*
Disease Models, Animal*
Cytokine Receptor gp130/*administration & dosage
Inflammation/*pathology
Interleukin-6/*metabolism
Methionine/*deficiency
Non-alcoholic Fatty Liver Disease/*pathology
Animals ; Biomarkers/metabolism ; Dietary Supplements ; Humans ; Inflammation/chemically induced ; Inflammation/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Non-alcoholic Fatty Liver Disease/chemically induced ; Non-alcoholic Fatty Liver Disease/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice.
Autorzy:: Lancaster GI; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Kraakman MJ; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Kammoun HL; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Langley KG; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Estevez E; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Banerjee A; Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Monash University, Victoria, Australia.
Grumont RJ; The Australian Centre for Blood Diseases and Department of Clinical Hematology, Monash University Central Clinical School, Melbourne, Victoria, Australia.
Febbraio MA; Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Gerondakis S; The Australian Centre for Blood Diseases and Department of Clinical Hematology, Monash University Central Clinical School, Melbourne, Victoria, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Nov 06; Vol. 9 (11), pp. e111524. Date of Electronic Publication: 2014 Nov 06 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Dual Specificity Phosphatase 2/*genetics
Glucose Intolerance/*genetics
Inflammation/*genetics
Insulin Resistance/*genetics
Obesity/*genetics
Adipose Tissue/metabolism ; Animals ; Blood Glucose/metabolism ; Diet, High-Fat ; Dual Specificity Phosphatase 2/metabolism ; Female ; Glucose Intolerance/metabolism ; Glucose Tolerance Test ; Inflammation/etiology ; Inflammation/metabolism ; Insulin/blood ; Male ; Mice ; Mutation ; Obesity/complications ; Obesity/metabolism ; Sex Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.
Autorzy:: Lancaster GI; Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Australia. />Kowalski GM
Estevez E
Kraakman MJ
Grigoriadis G
Febbraio MA
Gerondakis S
Banerjee A; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (6), pp. e39100. Date of Electronic Publication: 2012 Jun 11.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammation/*physiopathology
Insulin Resistance/*physiology
MAP Kinase Kinase Kinases/*deficiency
Obesity/*complications
Proto-Oncogene Proteins/*deficiency
Signal Transduction/*physiology
Adipose Tissue, White/metabolism ; Animals ; Biomarkers/metabolism ; Blotting, Western ; Body Composition/physiology ; DNA Primers/genetics ; Diet, High-Fat ; Gene Expression Profiling ; Inflammation/etiology ; MAP Kinase Kinase Kinases/genetics ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mitogen-Activated Protein Kinase 1/metabolism ; Mitogen-Activated Protein Kinase 3/metabolism ; Proto-Oncogene Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Kraakman MJ"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język